ZimVie Inc. (NASDAQ:ZIMV – Get Free Report)’s stock price dropped 3% on Monday . The stock traded as low as $21.01 and last traded at $21.02. Approximately 14,346 shares changed hands during trading, a decline of 96% from the average daily volume of 344,108 shares. The stock had previously closed at $21.67.
Analyst Upgrades and Downgrades
Separately, Needham & Company LLC restated a “buy” rating and set a $20.00 price objective on shares of ZimVie in a research report on Tuesday, June 25th.
Read Our Latest Report on ZimVie
ZimVie Stock Performance
ZimVie (NASDAQ:ZIMV – Get Free Report) last released its quarterly earnings results on Wednesday, May 8th. The company reported $0.08 EPS for the quarter. ZimVie had a negative net margin of 56.31% and a positive return on equity of 2.01%. The firm had revenue of $118.20 million during the quarter. During the same quarter last year, the company earned $0.25 EPS. As a group, research analysts anticipate that ZimVie Inc. will post 0.63 EPS for the current year.
Institutional Trading of ZimVie
Institutional investors and hedge funds have recently bought and sold shares of the business. Scarborough Advisors LLC purchased a new stake in ZimVie in the 4th quarter valued at $28,000. Summit Securities Group LLC raised its position in ZimVie by 518.6% during the 2nd quarter. Summit Securities Group LLC now owns 3,000 shares of the company’s stock worth $55,000 after buying an additional 2,515 shares during the last quarter. Heritage Wealth Advisors raised its position in ZimVie by 172,750.0% during the 1st quarter. Heritage Wealth Advisors now owns 6,914 shares of the company’s stock worth $114,000 after buying an additional 6,910 shares during the last quarter. EMC Capital Management purchased a new position in ZimVie during the 1st quarter worth $228,000. Finally, SG Americas Securities LLC raised its position in ZimVie by 27.2% during the 4th quarter. SG Americas Securities LLC now owns 14,152 shares of the company’s stock worth $251,000 after buying an additional 3,029 shares during the last quarter. Hedge funds and other institutional investors own 95.63% of the company’s stock.
ZimVie Company Profile
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Featured Stories
- Five stocks we like better than ZimVie
- Industrial Products Stocks Investing
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- What is MarketRankā¢? How to Use it
- Leading Gold Stock Shines With Q2 2024 Earnings Release
- 10 Best Airline Stocks to Buy
- Pharma Giant’s Shares Up After Impressive Q2 Earnings Release
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.